Zymeworks Inc. (ZYME)

Dec 20, 2024

Zymeworks (NYSE:ZYME) Shares Down 2.4%Here's Why - MarketBeat

Dec 20, 2024

Dec 20, 2024

Y Intercept Hong Kong Ltd Has $147,000 Stock Holdings in Zymeworks Inc. (NYSE:ZYME) - MarketBeat

Dec 20, 2024

Dec 19, 2024

Zymeworks (NYSE:ZYME) Stock Price Up 4.3% Following Analyst Upgrade - MarketBeat

Dec 19, 2024

Dec 19, 2024

Wells Fargo & Company Issues Positive Forecast for Zymeworks (NYSE:ZYME) Stock Price - MarketBeat

Dec 19, 2024

Dec 19, 2024

Zymeworks Stock: Prime Time Ziihera, Early-Stage Pipeline Ahead Of Schedule (NASDAQ:ZYME) - Seeking Alpha

Dec 19, 2024

Dec 18, 2024

Wellington Management Group LLP Has $3.05 Million Position in Zymeworks Inc. (NYSE:ZYME) - MarketBeat

Dec 18, 2024

Dec 17, 2024

JP Morgan Upgrades Zymeworks (ZYME) - MSN

Dec 17, 2024

Dec 16, 2024

Zymeworks (NYSE:ZYME) Shares Gap UpHere's Why - MarketBeat

Dec 16, 2024

Dec 16, 2024

Zymeworks (NYSE:ZYME) Upgraded at JPMorgan Chase & Co. - MarketBeat

Dec 16, 2024

Dec 12, 2024

Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases - The Manila Times

Dec 12, 2024

Dec 12, 2024

Zymeworks speeds up cancer drug development timeline - Investing.com

Dec 12, 2024

Dec 12, 2024

Zymeworks Hosts R&D Day Highlighting Continued Clinical - GlobeNewswire

Dec 12, 2024

Dec 12, 2024

Zymeworks Accelerates Cancer Drug Pipeline, Unveils Breakthrough Autoimmune Program 18 Months Ahead of Schedule - StockTitan

Dec 12, 2024

Dec 12, 2024

Zymeworks Inc. (NYSE:ZYME) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Dec 12, 2024

Dec 12, 2024

Zymeworks adjusts non-employee director pay By Investing.com - Investing.com Canada

Dec 12, 2024

Dec 11, 2024

Zymeworks adjusts non-employee director pay - Investing.com

Dec 11, 2024

Dec 06, 2024

Jacobs Levy Equity Management Inc. Sells 129,088 Shares of Zymeworks Inc. (NYSE:ZYME) - MarketBeat

Dec 06, 2024

Dec 06, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $19.13 Million Holdings in Zymeworks Inc. (NYSE:ZYME) - MarketBeat

Dec 06, 2024

Dec 05, 2024

Zymeworks Inc. (NYSE:ZYME) is Redmile Group LLC's 6th Largest Position - MarketBeat

Dec 05, 2024

Dec 03, 2024

Zymeworks Inc. (NYSE:ZYME) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 03, 2024

Nov 29, 2024

Vestal Point Capital LP Boosts Stake in Zymeworks Inc. (NYSE:ZYME) - MarketBeat

Nov 29, 2024

Nov 25, 2024

Bloom Burton Estimates Zymeworks FY2024 Earnings - MarketBeat

Nov 25, 2024

Nov 22, 2024

HC Wainwright Reaffirms Neutral Rating for Zymeworks (NYSE:ZYME) - MarketBeat

Nov 22, 2024

Nov 22, 2024

In-Depth Examination Of 9 Analyst Recommendations For Zymeworks - Benzinga

Nov 22, 2024

Nov 22, 2024

FDA approves cancer drug developed by B.C.'s Zymeworks - Head Topics

Nov 22, 2024

Nov 21, 2024

Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval - The Globe and Mail

Nov 21, 2024

Nov 21, 2024

FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework - Benzinga

Nov 21, 2024

Nov 21, 2024

Zymeworks to Showcase Innovations at Investor Conferences - TipRanks

Nov 21, 2024

Nov 21, 2024

Zymeworks Announces Participation in Upcoming Investor Conferences - The Manila Times

Nov 21, 2024

Nov 21, 2024

Zymeworks to Present at Major Healthcare Conferences, Announces R&D Day for Pipeline Updates | ZYME Stock News - StockTitan

Nov 21, 2024

Nov 21, 2024

FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for - GlobeNewswire

Nov 21, 2024

Nov 21, 2024

Zymeworks' Ziihera Wins FDA Approval: First Dual HER2 Cancer Drug Shows 52% Response Rate | ZYME Stock News - StockTitan

Nov 21, 2024

Nov 20, 2024

Leerink Partners Upgrades Zymeworks (ZYME) - MSN

Nov 20, 2024

Nov 15, 2024

Redmile Group, LLC Adjusts Stake in Zymeworks Inc - GuruFocus.com

Nov 15, 2024

Nov 12, 2024

Zymeworks stock soars to 52-week high, hits $17.29 By Investing.com - Investing.com Australia

Nov 12, 2024

Nov 11, 2024

Zymeworks stock soars to 52-week high, hits $17.29 - Investing.com India

Nov 11, 2024

Nov 11, 2024

Zymeworks (NYSE:ZYME) Stock Rating Upgraded by Leerink Partners - Defense World

Nov 11, 2024

Nov 11, 2024

FY2024 EPS Estimates for Zymeworks Lifted by Leerink Partnrs - MarketBeat

Nov 11, 2024

Nov 09, 2024

Analysts Update Their Estimates For Zymeworks BC Inc - Stocks Register

Nov 09, 2024

Nov 09, 2024

Q4 Earnings Estimate for Zymeworks Issued By Leerink Partnrs - Defense World

Nov 09, 2024

Nov 09, 2024

Zymeworks (NYSE:ZYME) Raised to Strong-Buy at Leerink Partnrs - Defense World

Nov 09, 2024

Nov 08, 2024

Leerink Partnrs Forecasts Zymeworks' Q4 Earnings (NYSE:ZYME) - MarketBeat

Nov 08, 2024

Nov 08, 2024

Zymeworks Inc. (NYSE:ZYME) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 08, 2024

Nov 08, 2024

Optimistic Investors Push Zymeworks Inc. (NASDAQ:ZYME) Shares Up 34% But Growth Is Lacking - Simply Wall St

Nov 08, 2024

Nov 08, 2024

Zymeworks (NYSE:ZYME) Upgraded to "Strong-Buy" at Leerink Partnrs - MarketBeat

Nov 08, 2024

Nov 07, 2024

Leerink lifts Zymeworks stock target on pipeline progress By Investing.com - Investing.com Nigeria

Nov 07, 2024

Nov 07, 2024

Leerink lifts Zymeworks stock target on pipeline progress - Investing.com

Nov 07, 2024

Nov 06, 2024

Zymeworks doses first subject in Phase I trial of ZW191 for solid tumours - Clinical Trials Arena

Nov 06, 2024

Nov 06, 2024

Citigroup Increases Zymeworks (NYSE:ZYME) Price Target to $18.00 - Defense World

Nov 06, 2024

Nov 05, 2024

Zymeworks Announces First Patient Dosed in Phase 1 Clinical - GlobeNewswire

Nov 05, 2024

Nov 05, 2024

Zymeworks Launches Phase 1 Trial for ZW191 - TipRanks

Nov 05, 2024

Nov 05, 2024

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors - The Manila Times

Nov 05, 2024

Nov 05, 2024

Zymeworks (NYSE:ZYME) Sets New 52-Week High Following Analyst Upgrade - Defense World

Nov 05, 2024